title: [Vascularization in transplantation of gene modified tissue engineered bone for repairing bone defect].
abstract: OBJECTIVE
  To study the vascularization of the composite of bone morphogenetic protein 2 (BMP-2) gene transfected marrow mesenchymal stem cells (MSCs) and biodegradable scaffolds in repairing bone defect.
  
  
  METHODS
  Adenovirus vector carrying BMP-2 (Ad-BMP-2) gene transfected MSCs and gene modified tissue engineered bone was constructed. The 1.5 cm radial defect models were made on 60 rabbits, which were evenly divided into 4 groups randomly (n= 15, 30 sides). Different materials were used in 4 groups: Ad-BMP-2 transfected MSCs plus PLA/PCL (group A), Ad-Lacz transfected MSCs plus PLA/PCL (group B), MSCs plus PLA/PCL (group C) and only PLA/PCL scaffolds (group D). The X-ray, capillary vessel ink infusion, histology, TEM, VEGF expression and microvascular density counting (MVD) were made 4, 8, and 12 weeks after operation.
  
  
  RESULTS
  In group A after 4 weeks, foliated formed bones image was observed in the transplanted bones, new vessels grew into the bones, the pores of scaffolds were filled with cartilage callus, osteoblasts with active function grew around the microvessels, and VEGF expression and the number of microvessels were significantly superior to those of other groups, showing statistically significant difference (P<0.01); after 8 weeks, increasingly more new bones grew in the transplanted bones, microvessels distended and connected with each other, cartilage callus changed into trabecular bones; after 12 weeks, lamellar bone became successive, marrow cavity recanalized, microvessels showed orderly longitudinal arrangement. In groups B and C, the capability of bone formation was weak, the regeneration of blood vessels was slow, after 12 weeks, defects were mostly repaired, microvessels grew among the new trabecular bones. In group D, few new vessels were observed at each time, after 12 weeks, broken ends became hardened, the defected area was filled with fibrous tissue.
  
  
  CONCLUSIONS
  BMP-2 gene therapy, by up-regulating VEGF expression, indirectly induces vascularization of grafts, promotes the living of seed cells, and thus accelerates new bone formation.
authors.affiliation: Department of Orthopaedics, Second Hospital of China Medical University, Shenyang Liaoning. lijianjun71@yahoo.com.cn
authors.forename: Jianjun
authors.initials: J
authors.lastname: Li
authors.forename: Dong
authors.initials: D
authors.lastname: Han
authors.forename: Hongbin
authors.initials: H
authors.lastname: Sun
mesh_terms: D000818:Animals; D001847:Bone Diseases / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D055396:Bone Morphogenetic Protein 2 / Q000235:genetics* / Q000378:metabolism; D001861:Bone Regeneration; D018786:Bone Substitutes; D004195:Disease Models, Animal; D059630:Mesenchymal Stem Cells; D055806:Microvessels; D009389:Neovascularization, Pathologic; D011817:Rabbits; D052416:Targeted Gene Repair; D023822:Tissue Engineering; D014162:Transfection
chemical_list: D055396:Bone Morphogenetic Protein 2; D018786:Bone Substitutes